PE20000423A1 - Derivado del acido 2-metilpropionico y composicion farmaceutica que lo contiene - Google Patents

Derivado del acido 2-metilpropionico y composicion farmaceutica que lo contiene

Info

Publication number
PE20000423A1
PE20000423A1 PE1999000296A PE00029699A PE20000423A1 PE 20000423 A1 PE20000423 A1 PE 20000423A1 PE 1999000296 A PE1999000296 A PE 1999000296A PE 00029699 A PE00029699 A PE 00029699A PE 20000423 A1 PE20000423 A1 PE 20000423A1
Authority
PE
Peru
Prior art keywords
cafiles
methylpropionic acid
pharmaceutical composition
composition containing
acid derivative
Prior art date
Application number
PE1999000296A
Other languages
English (en)
Inventor
Tetsuro Tamai
Nobuyuki Tanaka
Hideyuki Muranaka
Masaaki Sato
Masuo Akahane
Harunobu Mukaiyama
Akihito Hirabayashi
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of PE20000423A1 publication Critical patent/PE20000423A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/18—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE REFIERE A UN DERIVADO DEL ACIDO 2-METILPROPIONICO DE FORMULA I, DONDE R1 ES H, ALQUILO, ARALQUILO; R2 ES H, ALQUILO, HALOGENO; A ES O, IMINO. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. EL COMPUESTO I TIENE EFECTOS ESTIMULANTES DE ß3-ADRENOCEPTORES Y PUEDE SER UTIL PARA LA PREVENCION O TRATAMIENTO DE LA OBESIDAD, HIPERGLICEMIA, ENFERMEDADES CAUSADAS POR LA HIPERMOTILIDAD INTESTINAL, POLAQUIURIA, INCONTINENCIA URINARIA, DEPRESION, ENFERMEDDES CAUSADAS POR CALCULOS BILIARES, HIPERMOTILIDAD DEL TRACTO BILIAR
PE1999000296A 1998-04-14 1999-04-12 Derivado del acido 2-metilpropionico y composicion farmaceutica que lo contiene PE20000423A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14202898 1998-04-14

Publications (1)

Publication Number Publication Date
PE20000423A1 true PE20000423A1 (es) 2000-05-22

Family

ID=15305697

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1999000296A PE20000423A1 (es) 1998-04-14 1999-04-12 Derivado del acido 2-metilpropionico y composicion farmaceutica que lo contiene

Country Status (19)

Country Link
US (2) US6696489B1 (es)
EP (1) EP1072583B1 (es)
JP (1) JP4212771B2 (es)
KR (1) KR100576131B1 (es)
AR (1) AR015761A1 (es)
AT (1) ATE275126T1 (es)
AU (1) AU768217C (es)
CA (1) CA2328348C (es)
CO (1) CO5021214A1 (es)
DE (1) DE69919860T2 (es)
ES (1) ES2228028T3 (es)
IL (1) IL138994A (es)
MY (1) MY122400A (es)
NO (1) NO20005164L (es)
NZ (1) NZ507486A (es)
PE (1) PE20000423A1 (es)
TW (1) TW581754B (es)
WO (1) WO1999052856A1 (es)
ZA (1) ZA200005589B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE309978T1 (de) * 1999-01-21 2005-12-15 Kissei Pharmaceutical Kristall-polymorphismus von derivaten der aminoethyl-phenoxyessigsäure
CA2503570C (en) 2002-11-07 2011-04-19 Yamanouchi Pharmaceutical Co., Ltd. Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient
EP1424079A1 (en) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine
BRPI0407386A (pt) * 2003-02-14 2006-02-07 Kissei Pharmaceutical Derivados de álcool de amino, composições farmacêuticas contendo os mesmos e uso destes
ITMI20061581A1 (it) 2006-08-04 2008-02-05 Univ Bari Ligandi del recettore beta-3 adrenergico e loro uso in terapia
TWI478712B (zh) 2008-09-30 2015-04-01 Astellas Pharma Inc 釋控性醫藥組成物
US20120070465A1 (en) 2010-03-29 2012-03-22 Astellas Pharma Inc. Pharmaceutical composition for modified release

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146638A (en) * 1976-02-17 1979-03-27 Boehringer Ingelheim Gmbh N-(3-phenoxy-2-hydroxy-propyl)-n-(2-phenyl-2-hydroxy-ethyl)-amines
EP0023385B1 (en) * 1979-06-16 1982-12-15 Beecham Group Plc Ethanamine derivatives, their preparation and use in pharmaceutical compositions
FR2750668B1 (fr) 1996-07-03 1998-11-20 Savard Franck Dispositif de tension et de guidage d'une chaine pour un changement de vitesses de velo
AU4320297A (en) * 1996-09-26 1998-04-17 Kissei Pharmaceutical Co. Ltd. 2-amino-1-(4-hydroxy-2-methylphenyl)propanol derivatives
ID24062A (id) * 1997-07-25 2000-07-06 Kissei Pharmaceutical Turunan-turunan asam aminoetilfenoksiasetat dan obat untuk mengurangi nyeri dan membantu penyingkiran dalam litiasis saluran air kencing
JP4156799B2 (ja) * 1997-12-18 2008-09-24 キッセイ薬品工業株式会社 フェニルアミノアルキルカルボン酸誘導体およびそれを含有する医薬組成物

Also Published As

Publication number Publication date
CA2328348A1 (en) 1999-10-21
MY122400A (en) 2006-04-29
EP1072583A1 (en) 2001-01-31
EP1072583B1 (en) 2004-09-01
CA2328348C (en) 2009-03-03
US20030166719A1 (en) 2003-09-04
AR015761A1 (es) 2001-05-16
IL138994A0 (en) 2001-11-25
JP4212771B2 (ja) 2009-01-21
AU768217B2 (en) 2003-12-04
AU3166199A (en) 1999-11-01
KR20010042683A (ko) 2001-05-25
US6696489B1 (en) 2004-02-24
IL138994A (en) 2004-02-19
DE69919860T2 (de) 2005-08-25
CO5021214A1 (es) 2001-03-27
DE69919860D1 (de) 2004-10-07
TW581754B (en) 2004-04-01
US6790865B2 (en) 2004-09-14
WO1999052856A1 (fr) 1999-10-21
NO20005164L (no) 2000-12-12
NO20005164D0 (no) 2000-10-13
EP1072583A4 (en) 2001-12-05
KR100576131B1 (ko) 2006-05-03
ATE275126T1 (de) 2004-09-15
AU768217C (en) 2005-04-21
ZA200005589B (en) 2002-01-11
ES2228028T3 (es) 2005-04-01
NZ507486A (en) 2003-03-28

Similar Documents

Publication Publication Date Title
PE20000758A1 (es) Derivado del acido fenoxiacetico y composicion farmaceutica que lo contiene
BR0009864A (pt) Composto, composição farmacêutica, métodos para o tratamento de doenças, para o tratamento e/ou prevenção de condições mediadas pelos receptores nucleares e para o tratamento e/ou prevenção de diabete e/ou obesidade, e, uso de um composto
BRPI0517423A (pt) composto, composição farmacêutica, método para o tratamento ou prevenção de distúrbios neurológicos e psiquiátricos associados com disfunção do glutamato em um animal, e, uso em um composto
BRPI0411255A (pt) composto, composição farmacêutica, uso de um composto, métodos de tratar um distúrbio de um paciente, e, processo para a preparação de um composto
NO20015607D0 (no) Glukagonantagonister/inversagonister
EA200300316A1 (ru) Производные глюкопиранозилоксибензилбензола и содержащие их лекарственные композиции
BR0010555A (pt) Inibidores de neuraminidases
BRPI0412893A (pt) composto, composição farmacêutica, uso de um composto, e, métodos de prevenção, tratamento ou melhora de doenças ou condições inflamatórias, ou doenças ou condições oftálmicas, de tratamento ou melhora de cáncer e para a produção de um composto
EP1072592A3 (en) 4-arylpiperidine derivatives for the treatment of pruritus
BR0316877A (pt) Derivados de aril-quinazolina/aril-2-amino-fenil metanona que promovem a liberação de hormÈnio da paratireóide
EA200200194A1 (ru) Антагонисты хемокинного рецептора и способы их применения
EP1891954A3 (en) Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder
ES2143132T3 (es) Monohidratos de derivado de acido aminobenceno-sulfonico y su metodo de preparacion.
PE20000423A1 (es) Derivado del acido 2-metilpropionico y composicion farmaceutica que lo contiene
DK1395263T3 (da) 3, 7 eller 3 og 7 thia- eller oxaprostansyrederivater som midler til at sænke intraokulært tryk
CO5550443A2 (es) Derivados de 4-aril-2(1h)-quinazolina, su proceso de preparacion y una composicion farmaceutica que los contiene
CO5390085A1 (es) Metodo para tratar enfermedades o condiciones desmielinizantes
AR017858A1 (es) Derivados de acido fenilaminoalquilcarboxilico utiles como estimulantes de los beta3-adrenoceptores, composicion farmaceutica, estimulante de losbeta3-adrenoceptores, usos en la fabricacion de medicamentos y procedimiento de fabricacion
ATE281432T1 (de) C-16 ungesätigte fp-selektive prostaglandin analoge
AR037521A1 (es) Derivados de piperazina que tienen actividad antagonista del sst1, un proceso para su preparacion, composicion farmaceutica y el uso de dichos derivados para la manufactura de un medicamento para el tratamiento de la depresion, ansiedad y padecimientos bipolares y una combinacion
MXPA02012730A (es) Uso de acido pamoico o uno de sus derivados o uno de sus analogos para la preparacion de un medicamento para el tratamiento de enfermedades caracterizadas por depositos de agregados de amiloide.
PE20040668A1 (es) Nuevos derivados de piperidina
BR9909870A (pt) Pirrolidinas como inibidores de neuraminidases
BR0209284A (pt) Processo para preparação do fungicida agrìcola, azoxistrobina, e análogos do mesmo
SE0100684D0 (sv) New subject-matter

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed